CMS (Centers for Medicare & Medicaid Services) agrees to review carotid stenting policy
This article was originally published in Clinica
Executive Summary
The Centers for Medicare & Medicaid Services (CMS) has agreed to consider withdrawing its current non-coverage instructions for carotid artery stenting in light of the results from Cordis' recent SAPPHIRE trial. The Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy trial demonstrated that carotid stenting with embolic protection is not inferior to carotid endarterectomy and is a viable alternative for those patients who might not do well with the more invasive surgical procedure.
You may also be interested in...
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.